IDO1 and neoplasm: Because of its role in the development of immune tolerance to tumor antigens, the suppression of T and natural killer cells, and the generation and activation of T regulatory cells, IDO was extensively studied and IDO inhibitors, already found to be effective in preclinical studies are currently employed in clinical trials [159].